82 related articles for article (PubMed ID: 24596361)
1. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome.
Abbott DE; Brouquet A; Mittendorf EA; Andreou A; Meric-Bernstam F; Valero V; Green MC; Kuerer HM; Curley SA; Abdalla EK; Hunt KK; Vauthey JN
Surgery; 2012 May; 151(5):710-6. PubMed ID: 22285778
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy in breast cancers.
Masood S
Womens Health (Lond); 2016 Sep; 12(5):480-491. PubMed ID: 27885165
[TBL] [Abstract][Full Text] [Related]
3. Comparison of hormonal receptor and HER-2 status between breast primary tumours and relapsing tumours: clinical implications of progesterone receptor loss.
Bogina G; Bortesi L; Marconi M; Venturini M; Lunardi G; Coati F; Massocco A; Manfrin E; Pegoraro C; Zamboni G
Virchows Arch; 2011 Jul; 459(1):1-10. PubMed ID: 21643691
[TBL] [Abstract][Full Text] [Related]
4. The 21-gene recurrence score and locoregional recurrence in breast cancer patients.
Jegadeesh NK; Kim S; Prabhu RS; Oprea GM; Yu DS; Godette KG; Zelnak AB; Mister D; Switchenko JM; Torres MA
Ann Surg Oncol; 2015 Apr; 22(4):1088-94. PubMed ID: 25472643
[TBL] [Abstract][Full Text] [Related]
5. Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.
Flanagan MR; Rendi MH; Calhoun KE; Anderson BO; Javid SH
Ann Surg Oncol; 2015 Dec; 22(13):4263-9. PubMed ID: 25893410
[TBL] [Abstract][Full Text] [Related]
6. A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma
Mittal K; Toss MS; Wei G; Kaur J; Choi DH; Melton BD; Osan RM; Miligy IM; Green AR; Janssen EAM; Søiland H; Gogineni K; Manne U; Rida P; Rakha EA; Aneja R
Clin Cancer Res; 2020 Jun; 26(12):2898-2907. PubMed ID: 31937618
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and outcome of small (<=1 cm), node-negative breast cancer on the basis of hormonal and HER-2 status.
Amar S; McCullough AE; Tan W; Geiger XJ; Boughey JC; McNeil RB; Coppola KE; McLaughlin SA; Palmieri FM; Perez EA
Oncologist; 2010; 15(10):1043-9. PubMed ID: 20930097
[TBL] [Abstract][Full Text] [Related]
8. Basal-like breast carcinomas: clinical outcome and response to chemotherapy.
Banerjee S; Reis-Filho JS; Ashley S; Steele D; Ashworth A; Lakhani SR; Smith IE
J Clin Pathol; 2006 Jul; 59(7):729-35. PubMed ID: 16556664
[TBL] [Abstract][Full Text] [Related]
9. Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report.
Yeruva SLH; Javadi MS; Stearns V
Clin Breast Cancer; 2018 Jun; 18(3):e277-e280. PubMed ID: 29398467
[No Abstract] [Full Text] [Related]
10. Cardiovascular disease events within 5 years after a diagnosis of breast cancer.
Mery B; Fouilloux A; Rowinski E; Catella-Chatron J; Guichard JB; Da Costa A; Tinquaut F; Magné N; Bertoletti L
BMC Cancer; 2020 Apr; 20(1):337. PubMed ID: 32398106
[TBL] [Abstract][Full Text] [Related]
11. To study the survival analysis and recurrence pattern in women treated for breast cancer: Retrospective study, a tertiary cancer center experience from Sub-Himalayan Region of India.
Sundram S; Nandi S; Arora A; Saini S
J Surg Oncol; 2024 Apr; 129(5):843-849. PubMed ID: 38221665
[TBL] [Abstract][Full Text] [Related]
12. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
Choi YJ; Shin YD; Song YJ
World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
[TBL] [Abstract][Full Text] [Related]
13. Human epidermal growth factor receptor-2 positivity predicts locoregional recurrence in patients with T1-T2 breast cancer.
Cefaro GA; Genovesi D; Trignani M; DI Nicola M
Anticancer Res; 2014 Mar; 34(3):1207-12. PubMed ID: 24596361
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Molecular Subtype and Residual Disease on Locoregional Recurrence in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy and Postmastectomy Radiation.
Yang TJ; Morrow M; Modi S; Zhang Z; Krause K; Siu C; McCormick B; Powell SN; Ho AY
Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S495-501. PubMed ID: 26130454
[TBL] [Abstract][Full Text] [Related]
16. Breast Cancer in Men: a Report from the Department of Radiation Oncology in Kermanshah Province, Iran.
Amirifard N; Sadeghi E
Asian Pac J Cancer Prev; 2016; 17(5):2593-6. PubMed ID: 27268636
[TBL] [Abstract][Full Text] [Related]
17. Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Coates AS; Winer EP; Goldhirsch A; Gelber RD; Gnant M; Piccart-Gebhart M; Thürlimann B; Senn HJ;
Ann Oncol; 2015 Aug; 26(8):1533-46. PubMed ID: 25939896
[TBL] [Abstract][Full Text] [Related]
18. Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.
Ben Abdelkrim S; Fathallah K; Rouatbi R; Ayachi M; Hmissa S; Mokni M
Pathol Oncol Res; 2015 Jul; 21(3):553-61. PubMed ID: 25962349
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
